Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. (Q48316933)
Jump to navigation
Jump to search
scientific article published on 14 February 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. |
scientific article published on 14 February 2011 |
Statements
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease (English)
F Zerbib
S Bruley des Varannes
J-P Galmiche
J Tack
P Malfertheiner
14 February 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference